Inactivation of thiol-dependent enzymes by hypothiocyanous acid: role of sulfenyl thiocyanate and sulfenic acid intermediates
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Inactivation of thiol-dependent enzymes by hypothiocyanous acid : role of sulfenyl thiocyanate and sulfenic acid intermediates. / Barrett, Tessa J; Pattison, David I; Leonard, Stephen E; Carroll, Kate S; Davies, Michael Jonathan; Hawkins, Clare Louise.
In: Free Radical Biology & Medicine, Vol. 52, No. 6, 15.03.2012, p. 1075-85.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Inactivation of thiol-dependent enzymes by hypothiocyanous acid
T2 - role of sulfenyl thiocyanate and sulfenic acid intermediates
AU - Barrett, Tessa J
AU - Pattison, David I
AU - Leonard, Stephen E
AU - Carroll, Kate S
AU - Davies, Michael Jonathan
AU - Hawkins, Clare Louise
N1 - Copyright © 2012 Elsevier Inc. All rights reserved.
PY - 2012/3/15
Y1 - 2012/3/15
N2 - Myeloperoxidase (MPO) forms reactive oxidants including hypochlorous and hypothiocyanous acids (HOCl and HOSCN) under inflammatory conditions. HOCl causes extensive tissue damage and plays a role in the progression of many inflammatory-based diseases. Although HOSCN is a major MPO oxidant, particularly in smokers, who have elevated plasma thiocyanate, the role of this oxidant in disease is poorly characterized. HOSCN induces cellular damage by targeting thiols. However, the specific targets and mechanisms involved in this process are not well defined. We show that exposure of macrophages to HOSCN results in the inactivation of intracellular enzymes, including creatine kinase (CK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In each case, the active-site thiol residue is particularly sensitive to oxidation, with evidence for reversible inactivation and the formation of sulfenyl thiocyanate and sulfenic acid intermediates, on treatment with HOSCN (less than fivefold molar excess). Experiments with DAz-2, a cell-permeable chemical trap for sulfenic acids, demonstrate that these intermediates are formed on many cellular proteins, including GAPDH and CK, in macrophages exposed to HOSCN. This is the first direct evidence for the formation of protein sulfenic acids in HOSCN-treated cells and highlights the potential of this oxidant to perturb redox signaling processes.
AB - Myeloperoxidase (MPO) forms reactive oxidants including hypochlorous and hypothiocyanous acids (HOCl and HOSCN) under inflammatory conditions. HOCl causes extensive tissue damage and plays a role in the progression of many inflammatory-based diseases. Although HOSCN is a major MPO oxidant, particularly in smokers, who have elevated plasma thiocyanate, the role of this oxidant in disease is poorly characterized. HOSCN induces cellular damage by targeting thiols. However, the specific targets and mechanisms involved in this process are not well defined. We show that exposure of macrophages to HOSCN results in the inactivation of intracellular enzymes, including creatine kinase (CK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In each case, the active-site thiol residue is particularly sensitive to oxidation, with evidence for reversible inactivation and the formation of sulfenyl thiocyanate and sulfenic acid intermediates, on treatment with HOSCN (less than fivefold molar excess). Experiments with DAz-2, a cell-permeable chemical trap for sulfenic acids, demonstrate that these intermediates are formed on many cellular proteins, including GAPDH and CK, in macrophages exposed to HOSCN. This is the first direct evidence for the formation of protein sulfenic acids in HOSCN-treated cells and highlights the potential of this oxidant to perturb redox signaling processes.
KW - Animals
KW - Catalytic Domain
KW - Cell Line
KW - Creatine Kinase
KW - Enzyme Activation
KW - Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)
KW - Macrophages
KW - Mice
KW - Oxidative Stress
KW - Peroxidase
KW - Sulfenic Acids
KW - Sulfhydryl Compounds
KW - Thiocyanates
U2 - 10.1016/j.freeradbiomed.2011.12.024
DO - 10.1016/j.freeradbiomed.2011.12.024
M3 - Journal article
C2 - 22248862
VL - 52
SP - 1075
EP - 1085
JO - Free Radical Biology & Medicine
JF - Free Radical Biology & Medicine
SN - 0891-5849
IS - 6
ER -
ID: 128975162